Are there toxicological risks associated with long-term use?
Long-term use of PCSK9 inhibitors is still being studied, but current data suggests they are generally well-tolerated. However, there is an ongoing need for vigilance in monitoring potential adverse effects that might arise with prolonged use, particularly since these drugs are often prescribed for life-long management of hypercholesterolemia.
